REGN6569

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN6569, covering 2025-02-24 to 2025-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of REGN6569 and Cemiplimab in Adult Patients With Advanced Solid Tumor Malignancies [Phase 1]